Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Breast Cancer Management is Scopus-indexed (Q3, CiteScore 1.5). Published by Newlands Press Ltd.
Checked against the index lists dated .
ISSN 1758-1923Verify ISSN ↗1758-1931Verify ISSN ↗
Publisher: Newlands Press Ltd
Cost to publish: About US$1,415 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Radiology, Nuclear Medicine and Imaging | 247 / 361 | 31st | Q3 |
| Oncology | 309 / 428 | 27th | Q3 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2021–2024 (also 2018–2019, 2016, 2013), best quartile Q3, CiteScore 1.5.
Breast Cancer Management is Q3 in Radiology, Nuclear Medicine and Imaging (rank 247 of 361) and Q3 in Oncology (rank 309 of 428), by CiteScore 2025.
Breast Cancer Management is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 1.5, quartile Q3, 31st percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.213, quartile Q4, with an H-index of 4.
The publisher lists an article processing charge of about US$1,415 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Breast Cancer Management is published by Newlands Press Ltd. Its print ISSN is 1758-1923 and its online ISSN is 1758-1931.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
Breast Cancer Management has an h-index of 18 and a 2-year mean of 0 citations per paper (OpenAlex). Its Scopus CiteScore is 1.5, quartile Q3. On 2-year citations it ranks #323 of 346 Scopus journals in Radiology, Nuclear Medicine and Imaging.
Breast Cancer Management published 5 papers in 2023; its busiest recent year was 2014 with 51. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 18 research articles (2021–2023), authors are most often from Iran (19.4%), Italy (11.1%) and United States (11.1%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.